SkyKnight Capital Fund II, L.P. 的 Form 4 申報
AdaptHealth Corp.（AHCO），2022/6/13 申報
- 申報編號
- 0000899243-22-022193
- 申報時間
- 2022/6/13 16:35 ET
- 交易日
- 2022/6/9-6/10
- 申報延遲
- 4 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 2 筆非衍生性交易。公開市場買進合計 $24.3 萬。交易後 4 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| SkyKnight Capital Fund II, L.P.CIK 0001748212 | 董事 |
| Ebbel MatthewCIK 0001842704 | 董事 |
| SkyKnight Capital II GP, LLCCIK 0001842706 | 董事 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $17.47 to $17.50. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.
表 I 有 1 筆交易的價格引用這則附註。
- F3
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $17.06 to $17.50. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.
表 I 有 1 筆交易的價格引用這則附註。
備註
Theodore B. Lundberg has been deputized to represent the Reporting Persons on the board of directors of the Issuer. By virtue of Mr. Lundberg's representation, for purposes of Section 16 of the Securities Exchange Act of 1934 (the "Exchange Act"), each of the Reporting Persons may be deemed directors by deputization of the Issuer. This filing shall not be deemed an admission that any Reporting Person is a beneficial owner of the securities reported in this filing for purposes of Section 16 of the Exchange Act or otherwise, or is subject to Section 16 of the Exchange Act, and each Reporting Person disclaims beneficial ownership of these securities, except to the extent of such Reporting Person's pecuniary interest therein, if any.